Related Articles
β‑catenin blockers enhance the effect of CDK4/6 inhibitors on stemness and proliferation suppression in endocrine‑resistant breast cancer cells
Reversal of the tamoxifen‑resistant breast cancer malignant phenotype by proliferation inhibition with bromosulfonamidine amino‑podophyllotoxin
EZH2 inhibition sensitizes tamoxifen‑resistant breast cancer cells through cell cycle regulation
Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells
Changes in expression of steroid receptors, their downstream target genes and their associated co-regulators during the sequential acquisition of tamoxifen resistance in vitro